metricas
covid
Buscar en
Spanish Journal of Psychiatry and Mental Health
Toda la web
Inicio Spanish Journal of Psychiatry and Mental Health Metacognition in psychosis: What and how do we assess it?
Journal Information
Vol. 16. Issue 3.
Pages 206-207 (July - September 2023)
Share
Share
Download PDF
More article options
Visits
189
Vol. 16. Issue 3.
Pages 206-207 (July - September 2023)
Letter to the Editor
Full text access
Metacognition in psychosis: What and how do we assess it?
Visits
189
Luciana Díaz-Cutraroa,b,c, Helena García-Mieresa,b,d,h, Giancarlo Dimaggioe, Paul Lysakerf, Steffen Moritzg, Susana Ochoaa,b,d,
Corresponding author
Susana.ochoa@sjd.es

Corresponding author.
a Etiopatogènia i tractament dels trastorns mentals greus (MERITT), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat Institut de Recerca Sant Joan de Déu, Fundació Sant Joan de Déu, Spain
b Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
c Psychology Department, FPCEE Blanquerna, Universitat Ramon Llull, Barcelona, Spain
d Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
e Centro di terapia metacognitiva interpersonale, Roma, Italy
f Department of Psychiatry, School of Medicine, Indiana University, USA
g Department of Psychiatry and Psychotherapy, University Medical Center Hamburg, Hamburg, Germany
h IMIM Hospital del Mar Medical Research Institute | IMIM Health Services Group, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor,

Metacognition is a central aspect in the psychopathology of psychosis, and a key target of psychological treatments from various theoretical orientations in this population.1–3 Despite the different characterisations of this construct, the shared definition of metacognition includes the set of cognitive processes of which allows us to be aware of, reflect upon, control and regulate our mental states (thoughts and feelings) so to influence our experiences and behaviours and change our minds according to a higher-order understanding of psychological processes.4–6 Sometimes the boundaries between what is and is not metacognition are not clear. In this direction, a possible limit to trace this difference is the fact that if metacognition exists, we would have to encounter reflective processing, identification and/or change of psychological processes. For example, cognitive insight involves thinking about beliefs and interpretations,7 or social metacognition involves reflection on the decoding and processing of social information.8 More broadly, Lysaker et al. (2005)9 understand metacognition as a process of complex and integrated understanding about the self and others.

The importance given to metacognition in psychosis lies precisely in the regulatory and corrective functions involved in ways of thinking, doing and feeling, which are linked to better clinical outcomes, adaptation to the environment and understanding of everyday life experiences.10,11 The possibility of thinking about and reflecting on various cognitive processes could lead to improvements and adjustments in our functioning according to the different goals and contexts that make up our life domains.11,12 Conversely, failures and dysfunctionalities in metacognition could compromise different contexts in which we live such as social and affective relationships, work and education, and the capacity to sustain tasks of daily life.11,13 In psychosis, a compromised metacognitive architecture could lead to not understanding of self and social situations leading to the loss of a person's sense of purpose, possibilities, place in the world and cohesion of self, resulting in the subjective disturbances widely observed in this population.14

Research and clinical interest in metacognition in psychosis has been growing over the last decades. Alongside the different therapeutic approaches, the assessment and measurement of metacognition has also increased. In our first searches, we found that there are different metacognitive processes or domains addressed by different theoretical approaches and measures. Some of these measures are self-reported, such as the Beck Cognitive Insight Scale7 or The Metacognitions Questionnaire-30 (MCQ-30).15 Likewise while others instruments are conducted by clinicians, e.g. the Metacognition Assessment Scale (MAS and MAS-Abbreviated)9 and others measure metacognitive constructs with empirical approaches, as in the proposal of Koren et al. (2006)16 that assesses metacognition by adding to the WCST the degree of certainty with which decisions have been made.

We also observed that measures differ in the amount and complexity of training required from practitioners, the duration of the administration, number of items, and the field of application in which it is used (e.g., clinical or research). In addition, and considering the original proposal of Flavell (Flavell, 1979),12 who coined the term, we initially looked at measures that assess different characteristics of the four phenomena of metacognition: metacognitive knowledge, metacognitive experiences, tasks and goals and strategies or actions. These findings demonstrate the interest and availability of measures of metacognition that deserve to be collected and ordered so that different actors in our field can make use of them.

The main purpose and motivation for writing this letter to the editor is to inform the scientific community of the development of the present project and the scientific motivations for doing so. Due to the continuous growth and the numerous availability of measures, the project we are undertaking has as a general purpose to review the most used measures and the most explored metacognitive domains and functions. Bringing these measures together will help us to generate a first index to offer clinicians and researchers a streamlined way to know and decide which metacognition measures to use in the different domains of application.

We recognize that in daily practice, patient care times are short, waiting lists are long and human, economic and clinical resources are limited, so we believe that having an index of measures to assess such a central construct can simplify the clinical process. Likewise, in research, we have an extensive scientific production related to metacognition that, on the one hand, helps us to have a wide availability of measures and clinical trials that include interventions and metacognitive measures, but on the other hand, offers us redundant and confusing information about it.

Therefore, this review aims to build a first index of the most evaluated processes/levels/subdomains of metacognition in psychosis so far, by means of a systematic review of their corresponding assessment instruments (PROSPERO Registry: CRD42020198821). We will also organize the instruments according to fields of application (e.g., research, clinical), level of difficulty in applying the measure (e.g., training needed to use the measure, requirements for correcting the assessment), and psychometric properties.

Far from believing that this proposal will be definitive, we believe that this step will be the first of many for other colleagues interested in the field of psychosis to provide consensus and guidance on how to operationalize and measure metacognition. We hope to generate the expectation and interest necessary to connect research colleagues and clinicians in the field of metacognition from all over the world.

Contribution statement

Díaz-Cutraro, Luciana: idea, conceptualization, methodology, implementation, writing of manuscript.

García-Mieres, Helena: Supervision, conceptualization, methodology, edition of manuscript.

Dimaggio, Giancarlo: Supervision, conceptualization, edition of manuscript.

Lysaker, Paul: Supervision, conceptualization, edition of manuscript.

Moritz, Steffen: Supervision, conceptualization, edition of manuscript.

Ochoa, Susana: Supervision, conceptualization, methodology, edition of manuscript, research funding.

Conflict of interest

Dr. Steffen Moritz is the creator of metacognitive training for psychosis. Dr. Paul Lysaker devoloped the MERIT approach for psychosis. However, given that the present letter to the editor introduces a project consisting of a systematic review of tools for assessing metacognition in psychosis, and not of psychological therapies based on metacognition, we declare that we have no conflicts of interest with the present work.

Acknowledgments

LD-C is a beneficiary of the pre-doctoral grant FI19/00062, provided by the Instituto de Salud Carlos III (Government of Spain) within the framework of the PFIS Grants “Ayudas para la contratación de personal predoctoral”.

References
[1]
P. Hutton, A.P. Morrison, M. Wardle, A. Wells.
Metacognitive therapy in treatment-resistant psychosis: a multiple-baseline study.
Behav Cogn Psychother, 42 (2014), pp. 166-185
[2]
P.H. Lysaker, E. Gagen, S. Moritz, R.D. Schweitzer.
Metacognitive approaches to the treatment of psychosis: a comparison of four approaches.
Psychol Res Behav Manage, 11 (2018), pp. 341-351
[3]
S. Moritz, J.P. Klein, P.H. Lysaker, S. Mehl.
Metacognitive and cognitive-behavioral interventions for psychosis: new developments.
Dial Clin Neurosci, 21 (2019), pp. 309-317
[4]
P.H. Lysaker, S. Cheli, G. Dimaggio, et al.
Metacognition, social cognition, and mentalizing in psychosis: are these distinct constructs when it comes to subjective experience or are we just splitting hairs?.
BMC Psychiatry, 21 (2021), pp. 1-14
[5]
S. Moritz, P.H. Lysaker, S.G. Hofmann, M. Hautzinger.
Going meta on metacognitive interventions.
Expert Rev Neurotherap, 18 (2018), pp. 739-741
[6]
R. Philipp, L. Kriston, F. Kühne, M. Härter, R. Meister.
Concepts of metacognition in the treatment of patients with mental disorders.
J Ration Emot Cogn Behav Therapy, 38 (2020), pp. 173-183
[7]
A.T. Beck, E. Baruch, J.M. Balter, R.A. Steer, D.M. Warman.
A new instrument for measuring insight: The Beck Cognitive Insight Scale.
Schizophr Res, 68 (2004), pp. 319-329
[8]
R. Popolo, G. Vinci, F. D’Amato, et al.
The metacognitive functioning in schizophrenia: a proposal for assessment.
J Psychopathol, 21 (2015), pp. 133-140
[9]
P.H. Lysaker, A. Carcione, G. Dimaggio, et al.
Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight and quality of life.
Acta Psychiatr Scand, 112 (2005), pp. 64-71
[10]
S. Moritz, C. Andreou, B.C. Schneider, et al.
Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia.
Clin Psychol Rev, 34 (2014), pp. 358-366
[11]
A. Semerari, A. Carcione, G. Dimaggio, et al.
How to evaluate metacognitive functioning in psychotherapy? The metacognition assessment scale and its applications.
Clin Psychol Psychother, 10 (2003), pp. 238-261
[12]
J.H. Flavell.
Metacognition and cognitive monitoring: a new area of cognitive-developmental inquiry.
Am Psychol, 34 (1979), pp. 906-911
[13]
S.E. Riggs, P.M. Grant, D. Perivoliotis, A.T. Beck.
Assessment of cognitive insight: a qualitative review.
Schizophr Bull, 38 (2012), pp. 338-350
[14]
A.M. Schnakenberg Martin, P.H. Lysaker.
Metacognition, adaptation, and mental health.
Biol Psychiatry, (2021), pp. 1-2
[15]
M. Bright, S. Parker, P. French, et al.
Assessment of metacognitive beliefs in an at risk mental state for psychosis: a validation study of the Metacognitions Questionnaire-30.
Clin Psychol Psychother, 25 (2018), pp. 710-720
[16]
D. Koren, L.J. Seidman, M. Goldsmith, P.D. Harvey.
Real-world cognitive – and metacognitive – dysfunction in schizophrenia: a new approach for measuring (and remediating) more “right stuff.”.
Schizophr Bull, 32 (2006), pp. 310-326
Copyright © 2022. Sociedad Española de Psiquiatría y Salud Mental (SEPSM)
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos